Goodboy Picture Company/E+ via Getty ImagesBoston Scientific (NYSE:BSX) is set to report its second-quarter earnings on July 24. Expectations are high for this medical technologies giant following what has been an impressive share price rally in the first half of 2024. The stock is up 35% year-to-date, well ahead of healthcare sector benchmarks. We last covered BSX ahead of its first quarter report back in April highlighting the company's financial momentum, with new product launches driving a growth re ...